First Wave’s Adrulipase Disappoints In Third Phase II CF EPI Trial Despite New Formulation

Stock Down By 39%

 
• By Ayisha Sharma
  
graphic image of fat cells
Adrulipase Is Designed To Break Up Fat Molecules In The Digestive Tract • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D